Ingenix
Ingenix Raises €13M Seed Extension for AI Drug Development
Ingenix announced €13M in Seed Extension financing on June 3, 2026. Ingenix raised a €13 million seed extension led by Sofinnova Partners to scale its Biological Reasoning Engine, built on its Modality Fusion architecture.
Round details
The financing includes backing from Sofinnova Partners, Inovo VC, OTB VC. The company did not publish a valuation with the announcement.
- Round: Seed Extension
- Capital announced: €13M
- Headquarters: Warsaw
How the company plans to use the capital
Ingenix said the funding will scale development of its Biological Reasoning Engine and broaden its work with pharma and biotech partners through the Qualified Access Program, which launched on the announcement date.
Why this matters for GTM teams
Sofinnova Partners led the round, with Inovo VC and OTB VC participating, and Ingenix describes its Biological Reasoning Engine as built for translational and clinical R&D decisions.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Ingenix seed extension announcement.
Company Info
Investors (3)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


